Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first ...
After 100 years, the 12-lead electrocardiogram (ECG) remains the most accessible and inexpensive noninvasive diagnostic and prognostic tool in cardiology. Almost every hospitalized patient will ...
The Skeptical Cardiologist has been evaluating a demo version of AliveCor's new KardiaMobile 6L. I have been a huge advocate of Kardia's single-lead ECG and use it with great success in dozens of my ...
Background Interpretation of the athlete’s ECG is based on differentiation between benign ECG changes and potentially pathological abnormalities. The aim of the study was to compare the 2010 European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback